NEW YORK (GenomeWeb) – Quidel said after the close of the market on Wednesday that its fourth quarter revenues rose 27 percent year over year on strong infectious disease product sales.

For the three months ended Dec. 31, 2014, Quidel reported revenues of $63.6 million compared to $50.2 million in Q4 2013, and ahead of the consensus analysts' estimate of $61.1 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.